Epilepsy in inflammatory conditions

Risk of epilepsy among people with different inflammatory conditions, including systemic lupus erythematosus, rheumatoid arthritis, and type 1 diabetes is higher compared with those without inflammatory conditions.¹ Given this overlap, it is important to better understand the role of cytokines, chemokines and inflammatory markers to help develop novel therapeutic interventions to help people with epilepsy.¹

Reference:

1.Rana A, Musto AE. The role of inflammation in the development of epilepsy. J Neuroinflammation 2018; 15 (1): 144.